A Novel Small Peptide Inhibitor of NFκB, RH10, Blocks Oxidative Stress-Dependent Phenotypes in Cancer.
Jessica GambardellaMichele CiccarelliCarmine Del GiudiceAntonella FiordelisiMatteo De RosaMarina SalaRoberto PacelliPietro CampigliaTrimarco BrunoGuido IaccarinoDaniela SorrientoPublished in: Oxidative medicine and cellular longevity (2018)
Our data propose RH10 as a potential peptide-based drug to use for cancer treatment both alone or in combination with anticancer therapies.
Keyphrases